Companies /Healthcare
Beam Therapeutics Inc
NASDAQ: BEAM Biotechnology
$24.72
▼ $0.41 (−1.63%) today
Markets open · 10:01am ET

Beam Therapeutics (BEAM) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
50%
EPS beat rate
+51.61%
Avg. EPS surprise
Consecutive EPS misses
BEAM vs Market · 30-day return after each reportBEAMS&P 500
−20%0%+20%+16.2%+7.2%Q1 25+11.7%+3.1%Q2 25+19.1%+1.6%Q3 25−26.9%−6.2%Q4 25−3.2%+0.8%Q1 26+3.9%+0.2%Q2 26
−20%0%+20%Q1 25Q3 25Q1 26
BEAM EPS Trend · estimate vs actualEstimateActual
$-1.00$0.00$1.00$2.00$-1.17$-1.24Q1 25$-1.09$-1.00Q2 25$-1.03$-1.10Q3 25$-1.12$2.33Q4 25$-1.01$-0.91Q1 26$-1.13$-1.18Q2 26
$-1.00$0.00$1.00$2.00Q1 25Q3 25Q1 26
BEAM Revenue Trend · estimate vs actualEstimateActual
$0$40.0M$80.0M$120.0M$14.7M$7.5MQ1 25$13.3M$8.5MQ2 25$12.7M$9.7MQ3 25$12.9M$114.1MQ4 25$12.2M$31.7MQ1 26$17.2M$490,000Q2 26
$0$40.0M$80.0M$120.0MQ1 25Q3 25Q1 26

How Often Does Beam Therapeutics Beat Earnings Estimates?

Beam Therapeutics beat EPS estimates in 3 of its last 6 reported quarters.

BEAM quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q2 2026 $-1.18 est. $-1.13 −4.80% $490,000 est. $17.2M −97.15%
Q1 2026 $-0.91 est. $-1.01 +10.06% $31.7M est. $12.2M +159.70%
Q4 2025 $2.33 est. $-1.12 +308.97% $114.1M est. $12.9M +781.34%
Q3 2025 $-1.10 est. $-1.03 −7.10% $9.7M est. $12.7M −23.79%
Q2 2025 $-1.00 est. $-1.09 +8.37% $8.5M est. $13.3M −36.31%
Q1 2025 $-1.24 est. $-1.17 −5.86% $7.5M est. $14.7M −49.13%

Figures from SEC filings and company reports. Not investment advice.